Catalyst Wire Dossier Catalyst Wire Dossier

Semet

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Semet, covering 2014-11-27 to 2014-11-27. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Semet (80 and 160 mcg) Versus Placebo in Euthyroid Patients With AIT [Phase 2]

See pricing